RYAM Reports Narrower Q2 Loss as New CEO Vows Strategic Review by Year-End

  • RYAM reported a net loss of $33M for Q2 2026, significantly improved from the $363M loss in Q2 2025.
  • New CEO Daniel M. Krawczyk announced plans to conclude strategic review by Q4 2026.
  • Cellulose Specialties pricing increased 21% year-over-year, driven by higher pricing of newly negotiated agreements.
  • Company reorganized into two segments: High Purity Cellulose and Paperboard & High Yield Pulp.
  • Global liquidity stood at $145M as of June 27, 2026.

RYAM's Q2 results reflect ongoing operational improvements and strategic repositioning under new leadership. The company's focus on its Cellulose Specialties franchise and disciplined commercial execution aims to unlock value amid competitive market dynamics. The strategic review, expected to conclude by year-end, will be critical in determining the company's long-term trajectory.

Strategic Review Timeline
Whether RYAM can deliver on its promise to conclude the strategic review by Q4 2026 and communicate a clear path forward.
Operational Improvements
How effectively RYAM can sustain operational improvements and reliability initiatives across its manufacturing network.
Biomaterials Opportunities
The pace at which RYAM advances select biomaterials opportunities, particularly the Altamaha Green Energy project.